Timken Q2 Earnings Hit by $88M in Impairment Charges; Adjusted EPS Beats, Full-Year Guidance Raised
TKR sits 87% above its 52-week low of $70.565 on elevated volume (2.3× avg).
Summary
Timken reported Q2 GAAP EPS of $0.41, down sharply on $87.9M in impairment charges, but adjusted EPS of $1.83 beat expectations and full-year guidance was raised. The company is reshaping its portfolio with the Bijur Delimon acquisition and the planned sale of its belts business.
Key Events · Earnings and Guidance · TKR
-
Q2 GAAP EPS Plunges on Impairments
Net income attributable to Timken fell to $28.9M ($0.41 diluted EPS) from $78.5M ($1.12) a year ago, driven by $87.9M in impairment and restructuring charges, primarily from the belts divestiture and Springfield plant closure.
-
Adjusted EPS Beats, Guidance Raised
Adjusted EPS of $1.83 for Q2 2026 exceeded the prior-year $1.42. Full-year 2026 revenue growth is now expected at 5-6%, with adjusted EPS guidance raised, though GAAP earnings will be down slightly due to impairment charges.
-
Belts Business Divestiture and Plant Closure
Timken entered a definitive agreement to sell its belts business to Gates, recording a $64.4M impairment. The Springfield, MO belts facility will close, adding $14.6M in impairment and $2.7M in severance. Total pretax costs for these actions are estimated at $100M-$108M.
-
Bijur Delimon Acquisition Closed
The $124.4M acquisition of Bijur Delimon, a global automated lubrication systems maker, was completed in March 2026, adding $52M in goodwill and expanding the Industrial Motion segment.
Analysis · TKR · Technology
Timken's Q2 GAAP earnings were crushed by $87.9 million in impairment and restructuring charges tied to the planned sale of its belts business and a plant closure. Stripping those out, adjusted EPS of $1.83 handily beat the $1.42 from a year ago, and the company raised its full-year adjusted EPS guidance. The quarter also saw the acquisition of Bijur Delimon and a new $1.2 billion credit facility that extends maturities to 2031. The belts divestiture, expected to close in Q3, will remove an underperforming asset but comes with a painful $64.4 million write-down. The market will focus on the strong underlying operations and the strategic reshaping of the portfolio.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.5% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TKR was trading at $132.03 on NYSE in the Technology sector, with a market capitalization of approximately $9.2B. The 52-week trading range was $70.57 to $146.37. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.